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Abstract
Background Stereotactic biopsies for brainstem lesions are frequently performed to yield an accurate diagnosis and help guide
subsequent management. In this study, we summarize our experience with different stereotactic approaches to brainstem lesions
of different locations and discuss possible implications for safety and diagnostic yield.
Methods We retrospectively analyzed 23 adult patients who underwent a stereotactic biopsy for brainstem lesions between
October 2011 and December 2019. Depending on the location supra- or infratentorial, trajectories were planned.We assessed the
postoperative complications during the hospital stay as well as the diagnostic yield.
Results A supratentorial transfrontal approach was used in 16 (70%) cases, predominantly for lesions in the midbrain, upper
pons, and medulla oblongata. An infratentorial, transcerebellar-transpeduncular approach was used in 7 (30%) cases mainly for
lesions within the lower pons. All biopsies were confirmed to represent pathological tissue and a definitive diagnosis was
achieved in 21 cases (91%). Three patients (13%) had transient weakness in the contralateral part of the body in the immediate
postoperative period, which improved spontaneously. There was no permanent morbidity or mortality in this series of patients.
Conclusion Lesions of various locations within the brainstem can be successfully targeted via either a supratentorial transfrontal
or an infratentorial transcerebellar transpeduncular approach. Our high diagnostic yield of over 90% and the low rate of
complications underlines the diagnostic importance of this procedure in order to guide the medical management of these patients.
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Introduction
Brainstem lesions comprise 10–15% of all space occupying
lesions of the brain in children and 2% in adult patients [13,
15]. Many diffuse brainstem lesions in the pediatric population
do not warrant a biopsy due to the typical appearance on MR
imaging suggesting a diffuse brainstem glioma with no relevant
differential diagnoses [19]. In adults, however, pure radiologi-
cal findings will often fail to make the correct diagnosis, due to
the broader spectrum of underlying diseases including gliomas,
tumors of other origin, infectious diseases, infarctions, vasculi-
tis, demyelinating diseases, and gliosis [1, 6]. In fact, MRI-
based diagnosis is reported to be erroneous in 10–20% of the
cases [12]. Furthermore, the MRI accuracy to assess the tumor
classification and grading was estimated to be correct in only
35% of low-grade gliomas and 27% of high-grade gliomas
[17]. With growing importance of molecular markers for tumor
classification and guidance of treatment, together with increas-
ing safety and diagnostic yield of stereotactic biopsy of
brainstem lesions, the justification of specimen-based diagnosis
seems ever more important even in pediatrics population, as the
availability of biopsy material will allow for molecular biology
analysis including whole genome sequencing, thus potentially
allowing for the development of future therapies [15, 18].
Stereotactic biopsies of brainstem lesions can be performed
along different trajectories depending mainly on the location
of the lesion. Both supratentorial and transcerebellar ap-
proaches have been described with similar outcomes [22]. In
this study, we report our experience in 23 brainstem biopsies in
an adult population, including the spectrum of diagnosis, the
chosen trajectory, and the complications. Secondarily, we aim
to propose surgical biopsy trajectories (i.e., supratentorial
transfrontal or infratentorial transcerebellar, transpeduncular)
according to the anatomical location of the lesion.
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A consecutive series of twenty-three adult patients (16 males,
7 females) who underwent a stereotactic biopsy for a
brainstem lesion at the University Hospital Bern between
October 2011and December 2019 are included in this retro-
spective study. All adult patients who present with a brainstem
lesions without clear radiological or previously known diag-
nosis and/or which were not amenable to surgical resection
were selected for a stereotactic biopsy to confirm the diagnosis
in order to direct multidisciplinary treatment plans .The pa-
tients’mean age is 58 years (ranging 28 to 82 years) All cases
of radiologically demonstrated lesions localized to brainstem
were included in the study. In patients with larger lesions
involving other regions of brain, in addition to brainstem, or
multiple lesions, only the cases where the target of biopsy was
brainstem were included. All cases with a target outside the
brainstem were excluded. The mean duration of symptoms
was 4.2 months. Symptoms consisted of cranial nerve deficits
in 6, limb weakness in 5, gait disturbance in 3 patients, head-
ache and signs of increase intracranial pressure in 4, sensory
disturbances in 3, and 2 patients were not documented.
Patient’s demographic, clinical presentation, chosen trajecto-
ry, histological diagnosis, and complications are summarized
in Table 1. This study has been approved by the local ethics
committee (KEK number 2020-00440).
Pre-operative imaging
All patients underwent preoperative 3 Tesla MRI sequences
including 3D T1-weighted MPRAGE with contrast and 3D
T2-weighted sequences (voxel size 1 mm3) (Somaton,
Siemens, Erlangen, Germany). Magnetic resonance spectros-
copy (MRS) could be performed in only 11 patients due to
Table 1 Patient’s demographic, clinical presentation, chosen trajectory, histological diagnosis, and complications
Patient Age/
gender
Localization Presenting symptoms Approach Complications Histopathological diagnosis
1 39/F Diffuse
pontomedullary
Double image Transfrontal None Astrocytoma WHO grade II
2 76/F Pons hemiparesis Transcerebellar None EBV-associated CNS lymphoma
3 56/M Pontomesencephalone Hemiparesis, gait
instability
Transcerebellar None GBM, WHO grade IV
4 71/M Midbrain tegmentum headache Transfrontal None GBM, WHO grade IV
5 78/M Pontomedullary Double image Transcerebellar None Lymphoma
6 28/M Pontomedullary Paresthesia, dizziness Transcerebellar None Anaplastic astrocytoma WHO grade III
7 75/M Pontomesencephalone Double image Transfrontal Right sided
weakness
Anaplastic astrocytoma WHO grade III
8 58/M Pontomesencephalone Headache Transfrontal None Anaplastic astrocytoma WHO grade III
9 50/M Diffuse brainstem Gait instability Transfrontal None Anaplastic astrocytoma WHO grade III
10 70/M Midbrain Double image Transfrontal upper limb
weakness
CNS lymphoma
11 63/M Midbrain tegmentum Hemiparesis Transfrontal None GBM, WHO grade IV
12 82/F Midbrain Double image, gait
instability
Transfrontal None B-cell lymphoma
13 73/M Midbrain tectum Headache Transfrontal upper limb
weakness
GBM, WHO grade IV
14 66/F Midbrain Headache, double
vision,
Transfrontal None Metastaric neuroendocrine carcinoma
(colon CA)
15 67/M Pontomedullary Paresthesia Transcerebellar None B cell lymphoma
16 31/F Midbrain tegmentum Dizziness Transfrontal None Hypercellularity (Rosenthal fibers)
17 66/M Midbrain Not documented Transfrontal None Anaplastic astrocytoma WHO grade III
18 55/M Pontomedullary Dysphagia Transcerebellar None GBMWHO grade-IV
19 45/M Medulla oblongata Headache Transcerebellar None Ependymoma WHO grade II
20 37/F Pons Headache, double image Transfrontal None Pilocytic astrocytoma
21 40/M Midbrain Gait disturbances Transfrontal None Nonspecific gliosis with
microhemorrhage
22 60/M Pontomesencephalone Not documented Transfrontal None GBMWHO grade IV
23 68/M Pontomesencephalone Paresthesia Transfrontal None GBMWHO grade IV
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uncooperativeness of the patients. FDG-PET scan has been
performed in 5 cases where there was no clear enhancement
and/or because of reimbursement issues. Figure 1 illustrates
examples of brainstem lesions that were biopsied.
A stereotactic CT with contrast (voxel size 1 mm3) with the
Leksell stereotactic frame (Elekta, Stockholm, Sweden) was
performed on the day of surgery.
Trajectory planning
Surgical planning was performed with iPlan software (BrainLab,
Germany). The target was chosen in the center of the contrast
enhancing tumor or—in case of no enhancement—in the center
of the brightest T2 signal abnormality of the lesion. We chose a
supratentorial transfrontal trajectory in cases where the lesion
was in the midbrain, upper pons, and medulla oblongata.
Lesions in the lower pons that were accessible via the cerebellar
peduncles were targeted via an infratentorial, transcerebellar, and
transpeduncular approach (Fig. 2). All trajectories were planned
to avoid blood vessels, sulci, and the ventricles.
Surgical procedure
The surgical procedure was performed under general anesthe-
sia. Minimal shaving is limited to the entry point area. DIXI
guides tubes (DIXI, Besançon, France) were used to perform a
2.5-mm diameter burr hole strictly following the axis of the
defined trajectory and then insert the stereotactic needle used
for the biopsy.
In case of supratentorial transfrontal approach, the patient
was placed in a standard supine position, whereas semi-sitting
position was provided for transcerebellar approach. In some of
our transcerebellar cases, we removed one of the rear bars of
the frame in order to be able to perform the surgically planned
approach. Usually, three samples were collected for each pa-
tient by rotating the opening of the biopsy needle into different
direction and taking the subsequent samples but staying with-
in the same initially chosen target point. The first specimen
was used for frozen section processing to ensure positive sam-
pling. The second or the third specimen was used for the
definitive histological and molecular analysis or microbiology
Fig. 1 Overview of variety of
some of the lesions that were
biopsied. a–c T2W hyperintense,
non-enhancing lesion of the pons.
Histopathological diagnosis was
high-grade glioma. d–f T2W hy-
perintense, enhancing lesion of
the pons tegmentum.
Histopathological diagnosis was
astrocytoma WHO grade II. g–i
T2W hyperintense mass, with
enhancing foci of the medulla
oblongata. Histopathological di-
agnosis was ependymoma WHO
grade II
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if an infectious process was suspected. The average time for
the surgical procedure including the time needed for the fro-
zen section assessment by the pathologist was 45 min.
Routine postoperative imaging was not applied but re-
served for cases presenting a new neurological deficit after
the procedure or confirming that the tissue sample was col-
lected according to the planned target in case of diagnostic
failure.
Results
Lesion location and trajectory
The location of the lesion according to epicenter of contrast
enhancement or the T2-hyperintensity is shown in Table 2.
We applied a supratentorial transfrontal approach in all our
cases of midbrain lesions, as the transcerebellar transpeduncular
approach is limited because of the narrow superior cerebellar
peduncle and the very low entry point beyond the limits of the
frame ring angle (Fig. 3a, b, c). For pontine lesions, we used a
supratentorial transfrontal approach in 30% of the cases and
infratentorial transcerebellar transpeduncular approach in 70%
(Fig. 3d, e, f). The supratentorial transfrontal approach was used
in one case of medullary lesion as a transcerebellar
transpeduncular approach was technically not feasible due to a
resulting entry point above the tentorium (Fig. 3g, h, i).
Considering the whole cohort of patients, the transfrontal
approach was used in 16 (70%) cases and the transcerebellar
transpeduncular approach was used in 7 (30%) cases.
Surgical outcome
There was no mortality in this series. Three patients developed
transient neurological worseningwhich recovered spontaneously
a few days later without any further neurosurgical intervention.
One patient developed a contralateral upper and lower limb
weakness after a biopsy of an astrocytomaWHO grade III locat-
ed in the pontomesencephalic region. In this case, the biopsy was
at cerebral peduncle taken via a supratentorial transfrontal ap-
proach. The other two patients developed an upper limb weak-
ness after a biopsy of a lymphoma and a high-grade glioma
(WHO grade IV). Both lesions were located in the midbrain
tegmentum and the biopsy was taken via a supratentorial
transfrontal approach. The immediate postoperative CT scan
did not show any signs of hemorrhage, edema, or ischemia. No
complications were found with the infratentorial, transcerebellar-
transpeduncular approach.
Histological diagnosis
In all patients, the initial frozen sample confirmed pathologi-
cal tissue sampling. A conclusive definitive diagnosis was
Fig. 2 Diagram showing the
selected approach according to
the anatomical location of the
lesion in the different brainstem
regions
Table 2 Anatomical










made in 21 patients (91%). Confirmed histological diagnoses
are shown in Table 3.
Of the remaining two patients, one showed increased
cellularity with Rosenthal fibers and the other non-
specific gliosis with microhemorrhage. In both cases,
we performed a postoperative CT scan which confirmed
that the biopsy was performed in the targeted area. Both
patients were followed up closely with repeated radiolog-
ical and clinical assessment without changes of the clin-
ical status in both.
Fig. 3 Schematic coronal (left), sagittal (middle), and axial (right) representation of the cases and the used trajectories, midbrain cases (a, b, c), pons
cases (d, e, f), and medulla cases (g, h, i)
Table 3 Histopathological diagnosis of the biopsied brainstem lesions
Histopathology results Number of patients (%)
Astrocytoma WHO II 1 (4.3)
Astrocytoma WHO III 4 (17)




Pilocytic astrocytoma 1 (4.3)
Uncertain diagnosis 2 (9)
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Discussion
In this study, we present a systematic anatomical and
clinical analysis of different trajectories for brainstem bi-
opsies and propose an illustrative scheme to approach
these technically demanding lesions. In this series of 23
patients, both the supratentorial and infratentorial ap-
proaches yielded a definitive pathological diagnosis in
over 90% of the cases. Furthermore, both techniques were
not associated with long-term morbidity or mortality.
Transient neurological deterioration occurred in 13% of
our patients who underwent a biopsy of midbrain lesions
via a supratentorial transfrontal approach.
We used both supratentorial (transfrontal or transparietal)
and transcerebellar approaches. Both approaches have been
described and used by several groups [4, 5, 11, 15, 16, 22].
However, information about the choice of the trajectory relat-
ed to their precise location in the brainstem has not been spe-
cifically addressed in previous studies.
Depending on the exact location of the lesion in the
brainstem, we recommend the following approaches:
1. Midbrain lesions can be approached through a supratentorial
transfrontal approach. Choosing a gyrus near the coronal
suture as an entry point is feasible for anteriorly located
lesions (crus cerebri, as well as anterior tegmentum) and
may need to be adjusted more anteriorly (up to 2 cm anterior
to the coronal suture) for lesions located in the tectum (Fig.
4).
2. Lesions in the pons accessible through an infratentorial,
transcerebellar-transpeduncular approach should prefer-
entially be targeted by this approach due to the short tra-
jectory and paucity of any eloquent tracts or nuclei along
this trajectory. Superior pontine lesions as well as lesions
in the midline of the pons are often not accessible through
a transcerebellar-transpeduncular trajectory and a
supratentorial transfrontal approach can be performed in
these cases (Fig. 5).
3. Medullary lesions can be approached through a
supratentorial transfrontal approach. Alternatively,
in cases of a lesion located at the ponto-medullary
junction, a transcerebellar-transpeduncular approach
can be evaluated (Fig. 6). Selected superficial med-
ullary lesions could also be biopsied through an open
transcisternal approach.
We performed all our procedures under general anes-
thesia. Of note, most of the procedures described in liter-
ature were performed under local anesthesia and intermit-
tent intravenous sedation agent. Based on our results, we
think that performing brainstem biopsies under general
anesthesia is safe and offers a more tolerable atmosphere
for the patients. Furthermore, when performing proce-
dures within the brainstem, respiratory compromise is un-
predictable and sometimes catastrophic. Emergent intuba-
tion and resuscitation are occasionally required. We also
strictly control the intraoperative blood pressure. It is im-
possible to compare our values with other data obtained
from patients operated under local anesthesia, as these
values are not reported. Therefore, we are not able to
make any correlation about the intraoperative blood pres-
sure value and the bleeding risk.
Some previous studies have reported on complication
rates exceeding 10% [7, 10]. Furthermore, the diagnostic
yield of stereotactic biopsy for intracranial lesions shows
wide variations among different previous studies ranging
from 2 to 30% in some studies [8, 14] and more than 90%
in others. A recent meta-analysis of 38 studies reported a
diagnostic yield of 96.2% by weighted average propor-
tions analysis, which is comparable to our results [9].
Nevertheless, based on these observation, some authors
have even questioned the use of stereotactic biopsy for
these lesions [2, 3]. Interestingly, most of the lesions in
the present study were located in the midbrain or upper
pons and targeted with a supratentorial transfrontal ap-
proach and—consequently—a long trajectory tract. In
contrast, in many previous studies, the majority of lesions
were located in pons followed by medulla [7, 10, 20] but
no details on the chosen trajectories are provided. We
speculate that by using an infratentorial, transcerebellar-
transpeduncular approach for mid-pontine lesion that
come along with a shorter trajectory length within the
Fig. 4 Coronal (left), sagittal
(middle), and axial (right) T2-
weighted MRI images showing
the proposed midbrain regions of
interest (ROI) and the preferred
trajectory (red, crus cerebri;
green, tegmentum; blue, tectum)
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brainstem should decrease the risk of bleeding or the risk
of induced microlesion in that very eloquent area and
could be accountable for the variability of observed com-
plication rates.
Molecular markers of brain primary tumors such as
O6-methylguanin-DNS-methyltransferase (MGMT),
isocitratedehydrogenase-1 (IDH-1), and alpha-thalasse-
mia/mental retardation syndrome X-linked (ATRX) have
recently been shown to be correlated with chemotherapy
response and prognosis [21]. These markers can only be
determined by obtaining a tissue sample. This strongly
argues for the important role of brainstem biopsies to not
only confirm a suspected diagnosis but specify molecular
subtypes of tumors with implications on subsequent ther-
apeutic options.
There are some limitations for this study. The main lim-
itation is the small sample size of patients of our cohort
compromising a better estimate of complication rate and
the diagnostic yield of brain stem biopsies in general.
However, our results are in line with previous studies in-
cluding larger numbers of patients [5, 11, 15, 16].
Furthermore, the current results are based only on obser-
vations reflecting our targeting strategy and no conclusions
can be drawn if one of the two suggested approaches
would yield lower complication rates. To answer this ques-
tion, a prospective study or a retrospective case-control
study of similar lesions targeted via different approaches
and adequate sample size would be needed. On the other
hand, we can demonstrate the feasibility of the two ap-
proaches with similar outcome. Although we would pro-
pose to apply a transcerebellar-transpeduncular approach
whenever technically possible due to the shorter trajectory
length and less eloquent brain tissue along the tract, of
course, it remains the individual surgeon’s choice, which
approach to apply.
Conclusions
Stereotactic biopsies of brainstem lesions play an impor-
tant role in the diagnosis and subsequent treatment of pa-
tients, especially in the current era of fine molecular diag-
nosis and targeted chemotherapy. Supratentorial
transfrontal and transcerebellar-transpeduncular ap-
proaches can be applied and yield a high diagnostic accu-
racy and low morbidity. A specific trajectory according to
the specific location of the lesion should be considered
when approaching brainstem lesions. For midbrain lesion,
we suggest a supratentorial transfrontal approach; for pon-
tine lesion, a transcerebellar-transpeduncular trajectory
should be the first choice if the lesion is reachable from
that approach; and for medullary lesion, a transfrontal ap-
proach should be preferred unless the lesion is in the upper
part of the medulla where transcerebellar transpeduncular
approach can still be used.
Fig. 6 Coronal (left), sagittal
(middle), and axial (right) T2-
weighted MRI showing the me-
dulla oblongata region of interest
(ROI) and the proposed trajectory
Fig. 5 Posterior coronal (left),
sagittal (middle), and axial (right)
T2-weighted image showing the
proposed pons regions of interest
(ROI) and the preferred trajectory
(light blue, upper pons; blue, pons
at the level of the middle cerebel-
lar peduncle; green, pons
tegmentum)
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